The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis in women, according to study findings.

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Each year, a striking difference occurs in Australia when Shepard avocados briefly replace Hass at the shops. Here’s why.

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

Shares of TG Therapeutics rose after the company raised its guidance on better-than-expected sales of its multiple sclerosis drug. Shares were up 7.7% Tuesday to $29.79. The stock is about 18% below ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.